Table 1.
Baseline characteristics of AMP and APCS-PP-DALK groups.
| Variables | AMP group (n = 24) | APCS-PP-DALK group (n = 20) | p-value |
|---|---|---|---|
| Gender (n, %) | 0.601 | ||
| Male | 15 (62.5) | 14 (70.0) | |
| Female | 9 (37.5) | 6 (30.0) | |
| Age (years, mean ± SD) | 50.33 ± 13.33 | 56.70 ± 7.10 | 0.062 |
| BCVA (logMAR, mean ± SD) | 1.43 ± 0.73 | 1.63 ± 0.64 | 0.355 |
| Perforation diameter (mm, mean ± SD) | 1.25 ± 0.57 | 1.20 ± 0.54 | 0.770 |
| Ulcer diameter (mm, mean ± SD) | 2.89 ± 0.79 | 3.40 ± 1.07 | 0.080 |
| Primary etiology (n, %) | 0.375 | ||
| Infectious | 15 (62.5) | 15 (75.0) | |
| Non-infectious | 9 (37.5) | 5 (25.0) | |
| Perforation location (n, %) | 0.739 | ||
| Central | 9 (37.5) | 6 (30.0) | |
| Non-central | 15 (62.5) | 14 (70.0) | |
| Laterality (n, %) | 0.323 | ||
| Left | 4 (16.7) | 7 (35.0) | |
| Right | 20 (83.3) | 13 (65.0) | |
| Disease duration (n, %) | 0.845 | ||
| ≤7 days | 3 (12.5) | 4 (20.0) | |
| 8–14 days | 9 (37.5) | 7 (35.0) | |
| >14 days | 12 (50.0) | 9 (45.0) | |
| Concurrent hypopyon (n, %) | 2 (8.3) | 3 (15.0) | 0.488 |
| Comorbid systemic diseases (n, %) | 4 (16.7) | 3 (15.0) | 0.880 |
BCVA, best-corrected visual acuity.